Next Science Ltd (NXS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.498x

Based on the latest financial reports, Next Science Ltd (NXS) has a cash flow conversion efficiency ratio of 2.498x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.39 Million ≈ $-984.59K USD) by net assets (AU$-557.03K ≈ $-394.14K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Next Science Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Next Science Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Next Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Next Science Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Next Science Ltd ranked by their cash flow conversion efficiency. See NXS debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
China Crystal New Material KQ:900250	-0.016x
UTI Inc KQ:179900	-0.224x
Quantum Cyber N.V. NASDAQ:QUCY	-0.590x
Quilter PLC LSE:QLT	2.840x
Shanghai Lingyun Industries Development Co Ltd SHG:900957	-0.002x
CTK Co. Ltd KQ:260930	-0.017x
V-Tac Technology Co Ltd TWO:6229	-0.201x
Wattana Karnpaet Public Company Limited BK:NEW	0.042x

Annual Cash Flow Conversion Efficiency for Next Science Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Next Science Ltd from 2016 to 2024. View Next Science Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$3.44 Million ≈ $2.44 Million	AU$-7.96 Million ≈ $-5.63 Million	-2.313x	-96.95%
2023-12-31	AU$12.82 Million ≈ $9.07 Million	AU$-15.06 Million ≈ $-10.66 Million	-1.175x	-18.05%
2022-12-31	AU$11.85 Million ≈ $8.38 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.995x	-29.22%
2021-12-31	AU$10.73 Million ≈ $7.59 Million	AU$-8.26 Million ≈ $-5.85 Million	-0.770x	-21.55%
2020-12-31	AU$18.80 Million ≈ $13.30 Million	AU$-11.91 Million ≈ $-8.42 Million	-0.633x	+1.67%
2019-12-31	AU$19.37 Million ≈ $13.71 Million	AU$-12.48 Million ≈ $-8.83 Million	-0.644x	-31.02%
2018-12-31	AU$23.74 Million ≈ $16.80 Million	AU$-11.67 Million ≈ $-8.26 Million	-0.492x	-1532.03%
2017-12-31	AU$3.61 Million ≈ $2.55 Million	AU$-108.77K ≈ $-76.96K	-0.030x	+98.28%
2016-12-31	AU$1.34 Million ≈ $948.25K	AU$-2.35 Million ≈ $-1.66 Million	-1.751x	--

About Next Science Ltd

AU:NXS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.02 Million

AU$42.43 Million AUD

Market Cap Rank

#23875 Global

#929 in Australia

Share Price

AU$0.15

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.16

All Time High

AU$4.60